Esperite N.V.
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
09 feb 2016 - 07:17
Statutaire naam
Esperite N.V.
Titel
Esperite N.V. : GENOMA ENTERS THE SOUTH AFRICAN MARKET WITH INTERCARE
Bericht
Genoma continues its intercontinental expansion through a partnership with Intercare, a South African healthcare leader.
Geneva, Switzerland- 9th February 2016
Genoma is now present in the South African market. Thanks to a partnership with Intercare's firm Salubrity, Tranquility and Serenity are now the main players within the predictive medicine market in the Rainbow Nation.
With a population of 54 million, and a birth rate of 2.40, South Africa constitutes a strong market for Genoma's non-invasive prenatal test "Tranquility" and the breast and ovarian cancer screening test "Serenity". Thus, the exclusive partnership with a leading provider of integrated healthcare services in South Africa, guarantees a solid start to Genoma's offering within the country. Indeed, with its 4 day hospitals, 4 sub-acute and rehabilitation hospitals, and 16 medical centres, Intercare is a major player within the South African healthcare system, and so will Genoma.
Datum laatste update: 01 januari 2026